Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Childhood Dementia Explained by Synaptic Dysfunction, Opens New Therapies
Researchers at Flinders University used human iPSC-derived cortical neurons to model Sanfilippo syndrome, revealing that excitatory synapses become hyperactive early in development. This chronic overactivity mirrors the hyperactivity and sleep disturbances observed in affected children and appears to drive cognitive decline rather than being a downstream effect. The study also showed that mild nutrient deprivation amplifies synaptic abnormalities, suggesting common stressors can accelerate disease progression. Preliminary tests indicate that several existing drugs can normalize the synaptic imbalance, opening a path toward repurposed, personalized therapies for childhood dementia.
Beyond Consumer Use, Wearables May Be at a Clinical Turning Point
Wearable devices are moving from fitness accessories to clinical tools, as highlighted by Dr. Ami Bhatt, chief innovation officer of the American College of Cardiology, at HIMSS26. Sensors embedded in smart watches and patches can detect subtle physiological shifts that...
Unions Play Key Role in Keeping Direct Care Workers in the Workforce, Suggests Study
A UCLA-led study published in JAMA Network Open finds that unionized direct care workers (DCWs) experience significantly lower turnover than their non‑unionized peers, cutting overall attrition from 45% to 37%. The reduction spans nonprofit, for‑profit, and public sectors, translating into...
The Mismatch Between Social Value and Market Value
During a dinner with Dr. Devi Shetty, founder of Narayana Hospitals, the author notes the chain’s market capitalisation of roughly ₹38,000 crore (about $4.6 billion). By contrast, Indian fintech platforms such as Zerodha—whose primary product is a brokerage service—trade at higher valuations despite...
Post-HSCT Gilteritinib May Improve Outcomes in R/R FLT3-Mutated AML
A systematic review of eight studies suggests that post‑transplant gilteritinib maintenance may markedly improve survival for patients with relapsed or refractory FLT3‑mutated acute myeloid leukemia. One‑year overall survival rates ranged from 72.3% to 100%, while two‑year overall survival hovered around...
Roche Diagnostics Launches New Glucose Monitoring Device for Predicting Overnight Hypoglycemia in UK
Roche Diagnostics announced that its Accu‑Chek SmartGuide continuous glucose monitoring system is now reimbursable on the NHS, making the AI‑driven device available to adults with diabetes in the UK. The system uniquely predicts nighttime hypoglycaemia up to 30 minutes in...
Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference
Precision BioSciences (NASDAQ: DTIL) announced it will present at the 25th Annual Needham Virtual Healthcare Conference on April 14, 2026 at 9:30 am ET. The virtual session will showcase the company’s ARCUS® gene‑editing platform and its in‑vivo therapeutic pipeline, including programs...
Scientists Develop AI Tool to Spot Heart Failure Risk Five Years Before It Strikes
Oxford researchers have created an AI algorithm that reads routine cardiac CT scans to flag patients at risk of heart failure up to five years before symptoms appear. In a study of 72,000 NHS patients followed for a decade, the...
Cancer Risk Is Significantly Higher for Adults Who Have Never Married, Finds Large Study
A new U.S. study of over four million cancer cases finds adults who have never married face a markedly higher risk of developing cancer than those who are or have been married. The elevated risk spans most major cancer types,...
Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update
Bausch + Lomb received FDA 510(k) clearance for its Bi‑Blade™+ dual‑port vitrectomy cutter and the Adaptive Fluidics update on the Stellaris Elite system. The new cutter operates at 25,000 cuts per minute, a 66% speed boost over the prior model, and delivers a...
Americhem Announces Expansion of Global Healthcare Footprint with New China Investment at Chinaplas 2026
Americhem announced a new clean‑compounding facility in Suzhou, China, slated for the second half of 2026. The plant will be built to ISO 13485 and cGMP standards, extending the company’s regulated healthcare polymer network into Asia. At Chinaplas 2026 the firm will...
Rural Healthcare Transformation Has to Focus on the Real World, Not Techno-Fantasies
The CMS is rolling out $50 billion in Rural Health Transformation (RHT) grants to help under‑funded clinics streamline operations and improve care. Rural hospitals face chronic staffing shortages, shrinking patient volumes and thin margins, with more than 40% operating at a...
Still Using MRI for Early Degen Cervical Myelopathy? Why?
A recent systematic review finds spine surgeons often miss early degenerative cervical myelopathy (DCM) because conventional T2‑weighted MRI underdetects microstructural cord injury. Diffusion tensor imaging (DTI) and kinematic CT myelography outperform static scans by revealing fractional anisotropy changes and dynamic...
When Clinicians Prioritize Profit over Ethics, Patients Suffer
A clinician who puts money above integrity isn't just unethical, they're one of the greatest threats to their patient/client's wellbeing.
Sidewinder Therapeutics Raises $137 Million to Advance Bispecific ADCs
Sidewinder Therapeutics announced a $137 million Series B round, surpassing expectations and bringing its total capital to $162 million. The round was led by Frazier Life Sciences and Novartis Venture Fund, with participation from OrbiMed, DCVC Bio, Goldman Sachs, and others. The funding...
A New Way To Target Metastatic Cancer
Researchers have unveiled a protein‑based delivery platform that homes to lymph nodes and releases an immune‑activating antibody only in the presence of metastatic cancer. The two‑step system first accumulates in nodes after bloodstream injection, then opens in the tumor’s chemical...
Noninvasive Stool DNA Testing May Outperform Colonoscopy Long-Term in Real-World CRC Screening
A new microsimulation study published in the Journal of Medical Economics finds that three rounds of next‑generation multitarget stool DNA (mt‑sDNA) testing over ten years outperform a single colonoscopy in real‑world colorectal cancer (CRC) screening. Higher patient adherence—72% versus 38%...
Care Sector Recruitment Crisis Deepens as Fewer Workers Enter the Industry
A new analysis by Indeed’s Hiring Lab, reviewed by Caredemy, shows UK care homes facing a deepening recruitment crisis, with job‑seeker interest falling 15.9% since January 2025 and applicants per vacancy down 10.9%. The shortage is compounded by rising operating costs,...
Laura Blair: Balancing Virtual Fulfillment and Traditional Pharmacy Distribution
ConnectiveRx chief commercial officer Laura Blair says direct‑to‑patient (DTP) models and virtual fulfillment are reshaping pharmaceutical distribution, a shift accelerated by the surge in GLP‑1 therapies. She stresses that true DTP value lies in integrated benefits verification that matches patients...
Iowa AG Files Lawsuit Against Change Healthcare over 2024 Data Breach
Change Healthcare, a UnitedHealth Group subsidiary, faces a lawsuit filed by Iowa Attorney General Brenna Bird alleging violations of state consumer‑protection and data‑security laws. The suit stems from a February 2024 breach that went undetected for ten days, exposing Social...
Google Adds $30 M and New Safety Tools to Gemini for Mental‑health Help
Google announced today that its Gemini chatbot will now display a one‑touch crisis‑help card and a redesigned “Help is available” module when users show signs of distress. The company also committed $30 million over three years through Google.org to expand crisis‑helpline...
Digital Health Funding Concentrates in Fewer Startups: Report
Digital health startups secured $4 billion in the first quarter of 2026, up $1 billion from a year earlier, but the capital was funneled into fewer deals. Only 110 transactions occurred, down from 122, while a dozen mega‑deals of $100 million or more...
Psychedelic Study Maps Brain's Construction of the Self
Scientists reported that psychedelics temporarily loosen self‑related brain networks, enabling the first detailed mapping of how the brain constructs the sense of self. The finding, highlighted by The Hindu, could reshape spirituality research and therapeutic approaches to mental health.
Addressing the Crisis of Black Maternal Health: A Critical Role for Black Fathers
The United States faces a stark Black maternal health crisis, with mortality rates over 55 per 100,000 live births—more than triple the rate for white women. Over 80% of these deaths are deemed preventable through early intervention, yet systemic racism...
It’s Time to Put Guardrails on GLP-1 Compounding
The article warns that the rapid rise of compounded GLP‑1 drugs—spurred by a shortage of FDA‑approved semaglutide and tirzepatide—has created a largely unregulated market fraught with safety risks. The FDA recorded 1,150 adverse‑event reports, including hospitalizations and deaths, linked to...
Wim Hof Method Cuts Inflammation in Multiple Sclerosis Trial
A randomized pilot study of 60 multiple sclerosis patients showed that a 12‑week Wim Hof Method program significantly reduced blood inflammatory markers, matching the effect of a structured lifestyle intervention. Researchers say the findings support the method as a safe...
Vigorous Exercise Cuts Chronic Disease Risk 29‑61% in New Study
Researchers analyzing data from over 470,000 adults report that a higher proportion of vigorous physical activity—more than 4% of total exercise—reduces the risk of eight chronic diseases by 29% to 61% compared with no vigorous activity. The findings, published online...
Life Biosciences to Begin First Human Partial Reprogramming Trial in 2026
Life Biosciences, the Boston biotech co‑founded by David Sinclair, announced that its partial cellular reprogramming therapy will enter a first‑in‑human trial in 2026. The study will enroll 18 participants with glaucoma or non‑arteritic anterior ischemic optic neuropathy (NAION) and will...
What's Changed in Autism and ADHD?
The UK government’s interim report finds autistic traits remain steady in the population while diagnosis rates climb, a pattern echoed for ADHD. The rise reflects heightened awareness and broader diagnostic criteria rather than a true increase in prevalence. Clinicians now...
Skipping the Line: The Rise of Personal Healthcare Agents and On-Demand Care
Personal health agents such as ChatGPT Health, Claude for Healthcare, Copilot Health and Doctronic are moving from pilot projects to mainstream consumer tools, promising instant, AI‑driven medical advice. Doctronic alone has logged over 15 million AI‑mediated conversations, achieving 99.2 % treatment‑plan alignment...
Jefferson Health Sues Aetna over Medicare Advantage ‘Downcoding’ Policy
Jefferson Health and Lehigh Valley Physician Hospital Organization have filed a federal lawsuit against Aetna, alleging that the insurer’s new “downcoding” policy unlawfully reduces Medicare Advantage inpatient payments. The policy classifies 1‑4 night admissions as low‑severity and reimburses them at...
Researchers Develop Graphene Nanodrum and AI Platform for Rapid Single-Cell Bacterial ID and Antibiotic Testing
Researchers at TU Delft, its spin‑off SoundCell, and Reinier Haga MDC have created a graphene‑based nanodrum platform that reads the nanomotion of individual bacteria and feeds the data to AI models for rapid identification and antibiotic susceptibility testing. The label‑free...
Hospital Expansion Reimagines Healthcare Settings with Spatial Layout
Fleurimont Hospital in Sherbrooke, Quebec, has completed a 34,500 m² (371,355 sf) expansion that adds the Enfant Soleil Pavilion, consolidating emergency, maternity, neonatal, pediatric and child‑psychiatry services. The project used a collaborative design process involving clinicians, artists, managers and patient partners to...
HHS Issues New Guidelines for Food Served in Hospitals
The U.S. Department of Health and Human Services (HHS) issued a memo directing hospitals to align their food service policies with the 2025‑2030 Dietary Guidelines. The rules require eliminating ultra‑processed foods, sugary drinks, refined grains, and processed meats, while mandating...
Navigating Dense Breast Tissue and Breast Cancer Screening Guidelines
Physician‑author Amantia Kennedy shares her personal breast‑cancer diagnosis to highlight how heterogeneously or extremely dense breast tissue can mask tumors on standard mammograms. In 2024 the FDA mandated that radiology reports disclose breast‑density categories, and the 2025 NCCN guidelines now...
Extracellular Vesicles: A Growing Pipeline Still Searching for Validation
Extracellular vesicles (EVs), once hailed as natural delivery vehicles, have generated a sizable pipeline but no approved therapeutics yet. More than 90 clinical studies are evaluating both native MSC‑derived vesicles and engineered platforms for regeneration, gene editing, and vaccines. Companies...
MRNA Pioneer Katalin Karikó to Give Johns Hopkins Commencement Address
Nobel laureate Katalin Karikó will deliver the commencement address at Johns Hopkins on May 21. Karikó, whose mRNA work underpins the Pfizer/BioNTech and Moderna COVID‑19 vaccines, will receive a Doctor of Humane Letters. Her career, marked by early setbacks and decades‑long...
The Power Behind Enterprise EHR Software for Large Healthcare Systems
Enterprise electronic health record (EHR) platforms are becoming the operational backbone for large healthcare systems, offering a unified, cloud‑based architecture that supports multiple facilities, specialties, and tax entities. Core capabilities include real‑time data synchronization, API‑first interoperability, built‑in HIPAA and ONC...
More On Raw Milk
The current HHS secretary is championing raw, unpasteurized milk despite FDA warnings, reigniting public debate. Epidemiological data show raw milk causes roughly 840 times more illnesses and 45 times more hospitalizations than pasteurized milk, with 143 CDC‑recorded outbreaks from 2009‑2021....
AI Eye Scans Reveal Heart Risk, Yet Care Pathway Lags
My eye doctor gave me a cardiovascular risk score from my retinal scan. New data from ACC.26: an AI system analyzing routine eye exam images identified elevated heart disease risk with 91% sensitivity. Matched the standard cardiologist risk calculator. One in...
Healthcare's Consumer Shift: Inevitable Correction, Not Disruption
The consumerization of healthcare feels less like disruption and more like a correction. Every other industry moved toward convenience, transparency, and user control decades ago. Healthcare was always going to follow. #health #healthcare https://t.co/44LrXpyrx3
![[Scuttlebit] Thermo Fisher Update](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://substackcdn.com/image/fetch/$s_!ckOZ!,w_256,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fscuttleblurb.substack.com%2Fimg%2Fsubstack.png)
[Scuttlebit] Thermo Fisher Update
Thermo Fisher, nearly twice the size of Danaher, has broadened its life‑sciences footprint beyond pure products to include services such as clinical‑trial execution and drug manufacturing. The company’s Life Sciences segment, built on the 2014 $15 billion Life Technologies acquisition, now...
Lymph-Node CD8+ T Cells Amplify PD-1 Blockade in GI Cancer
PD-1 antibody-bound progenitor-exhausted CD8+ T cells in lymph nodes boost PD-1-blockade anti-tumor immunity in gastrointestinal cancer https://t.co/VKoxzy6oUq https://t.co/cQG2sLWtL2
Long Covid Will Drain OECD Economies $135 Billion Annually
Long Covid predicted to cost OECD economies $135 billion a year https://t.co/4KeKqtPpWP via @ashleighfurlong https://t.co/LDMSBeZh3Y
Hospitals Still Drive the Largest HSA Dollars
Lively’s 2026 HSA Spend Report shows hospitals still command the biggest dollar volume, but retail giants, e‑commerce sites and digital health providers are rapidly climbing the merchant rankings. Amazon, Lilly, Warby Parker, 1‑800 Contacts and mental‑health platforms like BetterHelp now...
NRH Prevents Age‑related Hearing Loss via Sirt3‑mediated Ferroptosis Suppression
NRH attenuates age-related hearing loss by suppressing cochlear ferroptosis and cellular senescence via Sirt3 activation https://t.co/MOqQblWYNM https://t.co/uhSMXRIxDK
Controversial Drugs Once Feared, Now Offer Hope
A decade ago, these drugs tore apart the FDA. Today, they might be some patients’ best hope Another wonderful piece from @Jasonmmast https://t.co/zOvLrdAPKi via @statnews
Insmed Scraps Skin Plans for Lung Disease Drug as Competitors Make Headway
Insmed announced it will drop development of its lung‑disease drug Brinsupri for hidradenitis suppurativa after the Phase 2b CEDAR trial showed no efficacy, with placebo outperforming both tested doses. The study also missed secondary endpoints, prompting the company to cease the...
The Complex Link Between Poverty and Health
The relationship between poverty and health is bidirectional and varies by context, making policy solutions complex. Research shows a steep health gain as income rises from extreme poverty, but additional wealth yields diminishing returns. Cash‑transfer programs produce mixed health outcomes,...
Asthma Exacerbations Drop with Medium-Dose ICS to Biologic Switch
A recent analysis of 2016‑2023 Optum claims data shows that asthma patients who switched from a medium‑dose inhaled corticosteroid (ICS) directly to a biologic experienced markedly larger reductions in exacerbations and systemic corticosteroid fills than those who escalated to high‑dose ICS....